BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 7801128)

  • 1. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.
    Kalpana GV; Marmon S; Wang W; Crabtree GR; Goff SP
    Science; 1994 Dec; 266(5193):2002-6. PubMed ID: 7801128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative molecular genetic analysis of simian and human HIV-1 integrase interactor INI1/SMARCB1/SNF5.
    Pyeon D; Price L; Park IW
    Arch Virol; 2015 Dec; 160(12):3085-91. PubMed ID: 26350979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV integration. Ini1 for integration?
    Miller MD; Bushman FD
    Curr Biol; 1995 Apr; 5(4):368-70. PubMed ID: 7627549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
    Masuda T; Planelles V; Krogstad P; Chen IS
    J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
    Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
    Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences.
    Bushman FD
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9233-7. PubMed ID: 7937746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein.
    Goulaouic H; Chow SA
    J Virol; 1996 Jan; 70(1):37-46. PubMed ID: 8523550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.
    Yung E; Sorin M; Wang EJ; Perumal S; Ott D; Kalpana GV
    J Virol; 2004 Mar; 78(5):2222-31. PubMed ID: 14963118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase.
    Chow SA; Brown PO
    J Virol; 1994 Dec; 68(12):7869-78. PubMed ID: 7966577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.
    Vincent KA; Ellison V; Chow SA; Brown PO
    J Virol; 1993 Jan; 67(1):425-37. PubMed ID: 8416376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.
    Katzman M; Sudol M
    J Virol; 1995 Sep; 69(9):5687-96. PubMed ID: 7637015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites.
    Tan W; Zhu K; Segal DJ; Barbas CF; Chow SA
    J Virol; 2004 Feb; 78(3):1301-13. PubMed ID: 14722285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
    Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
    Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 DNA integration: fine structure target analysis using synthetic oligonucleotides.
    Hong T; Murphy E; Groarke J; Drlica K
    J Virol; 1993 Feb; 67(2):1127-31. PubMed ID: 8419642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between Nef and INI1/SMARCB1 augments replicability of HIV-1 in resting human peripheral blood mononuclear cells.
    Pyeon D; Park IW
    Arch Virol; 2015 Mar; 160(3):727-37. PubMed ID: 25559666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo.
    Mathew S; Nguyen M; Wu X; Pal A; Shah VB; Prasad VR; Aiken C; Kalpana GV
    Retrovirology; 2013 Jun; 10():66. PubMed ID: 23799881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection.
    Leavitt AD; Robles G; Alesandro N; Varmus HE
    J Virol; 1996 Feb; 70(2):721-8. PubMed ID: 8551608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of DNA binding property of the HIV-1 host factor and tumor suppressor protein Integrase Interactor 1 (INI1/hSNF5).
    Das S; Banerjee B; Hossain M; Thangamuniyandi M; Dasgupta S; Chongdar N; Kumar GS; Basu G
    PLoS One; 2013; 8(7):e66581. PubMed ID: 23861745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the SNF5 transcription factor gene abolishes the lethal phenotype induced by the expression of HIV-1 integrase in yeast.
    Parissi V; Caumont A; Richard de Soultrait V; Dupont CH; Pichuantes S; Litvak S
    Gene; 2000 Apr; 247(1-2):129-36. PubMed ID: 10773452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrase interactor 1 (Ini1/hSNF5) is a repressor of basal human immunodeficiency virus type 1 promoter activity.
    Boese A; Sommer P; Holzer D; Maier R; Nehrbass U
    J Gen Virol; 2009 Oct; 90(Pt 10):2503-2512. PubMed ID: 19515827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.